equilibrative nucleoside transporter deficiency perturbs lysosome function macrophage homeostasis 
lysosomal storage diseases lsds group heterogeneous disorders caused defects lysosomal enzymes transporters resulting accumulation undegraded macromolecules metabolites macrophage numbers expanded several lsds leading histiocytosis unknown pathophysiology found mice lacking equilibrative nucleoside transporter ent3 developed spontaneous progressive macrophage-dominated histiocytosis absence ent3 defective apoptotic cell clearance led lysosomal nucleoside buildup elevated intralysosomal ph altered macrophage function macrophage accumulation partly due increased macrophage colony-stimulating factor receptor expression signaling secondary lysosomal defects studies suggest cellular molecular basis development histiocytosis several human syndromes associated ent3 mutations potentially lsds 
